United States Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Description

List of Tables

GlobalData's "United States Oncology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The United States Oncology Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2024 company share data for Oncology Market.
Global corporate-level profiles of key companies operating within the United States Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Oncology is segmented as follows -

Colorectal Cancer Screening Tests
EGFR Tests
KRAS Tests
HER2 Tests
BRCA Tests
ALK Tests
BRAF Tests
BCR-ABL Tests
PD-L1 Tests

Reasons to Buy

The United States Oncology Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME25630CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Oncology Market, United States

3.1 Oncology Market, United States, Revenue ($m), 2018-2033
- 3.1.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 BCR-ABL Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.3 BRAF Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.4 BRCA Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.5 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.6 EGFR Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.7 HER2 Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.8 KRAS Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, United States, Volume (Units), 2018-2033
- 3.2.1 ALK Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 BCR-ABL Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.3 BRAF Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.4 BRCA Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.5 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.6 EGFR Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.7 HER2 Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.8 KRAS Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, United States, Average Price ($) , 2018-2033
3.4 Oncology Market, United States, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United States, Oncology Market

5 Oncology Market Pipeline Products

6 Financial Deals Landscape

7 Recent Developments

8 Appendix

Product Code: GDME25630CCDB

List of Table

List of Tables

Table 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, United States, Volume (Units), 2018-2033
Table 11: ALK Tests Market, United States, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, United States, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, United States, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, United States, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, United States, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, United States, Volume (Units), 2018-2033
Table 19: Oncology Market, United States, Average Price ($), 2018-2033
Table 20: Oncology Market, United States, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
Table 23: Hanmi Pharma and LG Invests USD5 Million in MEDiC Life Sciences
Table 24: Starboard Value May Acquire Stake in Pfizer for USD1 Billion
Table 25: VION Biosciences Acquires Ansh Labs
Table 26: DERM-JES Holdings Acquires DermTech
Table 27: Breath Diagnostics Raises USD1 Million in Private Placement of Convertible Notes
Table 28: Kiyatec Raises USD0.25 Million in Debt Offering
Table 29: Laboratory Corp of America Holdings Raises USD650 Million in Public Offering of 4.35% Notes Due 2030
Table 30: Laboratory Corp of America Holdings Raised Public Offering of 4.55% Notes Due 2032 for USD500 Million
Table 31: Laboratory Corp of America Holdings Raises USD850 Million in Public Offering of 4.8% Notes Due 2034
Table 32: Illumina Prices USD500 Million in Public Offering of 4.65% Notes Due 2026
Table 33: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

Figure 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, United States, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, United States, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, United States, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, United States, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, United States, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, United States, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, United States, Volume (Units), 2018-2033
Figure 19: Oncology Market, United States, Company Share (%), 2024